SLC5A2 and endothelial dysfunction: The issue also remains open regarding the many human and animal data suggesting multiple possible pathways mediated by SGLT2 inhibition, not only through glucose-lowering, but also lipid metabolism and foam cell formation, vascular inflammation and oxidative stress, endothelial dysfunction, and prevention of platelet activation, as discussed in recent reviews [200,201].